440 related articles for article (PubMed ID: 12564745)
1. Comparative bioavailability of two novel coenzyme Q10 preparations in humans.
Joshi SS; Sawant SV; Shedge A; Halpner AD
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):42-8. PubMed ID: 12564745
[TBL] [Abstract][Full Text] [Related]
2. A new Coenzyme Q10 tablet-grade formulation (all-Q) is bioequivalent to Q-Gel and both have better bioavailability properties than Q-SorB.
Ullmann U; Metzner J; Schulz C; Perkins J; Leuenberger B
J Med Food; 2005; 8(3):397-9. PubMed ID: 16176154
[TBL] [Abstract][Full Text] [Related]
3. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system.
Liu ZX; Artmann C
Altern Ther Health Med; 2009; 15(2):42-6. PubMed ID: 19284181
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability assessment of oral coenzyme Q10 formulations in dogs.
Zaghloul AA; Gurley B; Khan M; Bhagavan H; Chopra R; Reddy I
Drug Dev Ind Pharm; 2002 Nov; 28(10):1195-200. PubMed ID: 12476865
[TBL] [Abstract][Full Text] [Related]
5. Relative bioavailability of coenzyme Q10 formulations in human subjects.
Chopra RK; Goldman R; Sinatra ST; Bhagavan HN
Int J Vitam Nutr Res; 1998; 68(2):109-13. PubMed ID: 9565826
[TBL] [Abstract][Full Text] [Related]
6. Stability and bioequivalence studies of two marketed formulations of coenzyme Q10 in beagle dogs.
Kommuru TR; Ashraf M; Khan MA; Reddy IK
Chem Pharm Bull (Tokyo); 1999 Jul; 47(7):1024-8. PubMed ID: 10434405
[TBL] [Abstract][Full Text] [Related]
7. Relative bioavailability and antioxidant potential of two coenzyme q10 preparations.
Kurowska EM; Dresser G; Deutsch L; Bassoo E; Freeman DJ
Ann Nutr Metab; 2003; 47(1):16-21. PubMed ID: 12624483
[TBL] [Abstract][Full Text] [Related]
8. Relative bioavailability of two forms of a novel water-soluble coenzyme Q10.
Zmitek J; Smidovnik A; Fir M; Prosek M; Zmitek K; Walczak J; Pravst I
Ann Nutr Metab; 2008; 52(4):281-7. PubMed ID: 18645245
[TBL] [Abstract][Full Text] [Related]
9. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization.
López-Lluch G; Del Pozo-Cruz J; Sánchez-Cuesta A; Cortés-Rodríguez AB; Navas P
Nutrition; 2019 Jan; 57():133-140. PubMed ID: 30153575
[TBL] [Abstract][Full Text] [Related]
11. Relative bioavailability of coenzyme Q10 formulation for paediatric individualized therapy.
Martinefski M; Samassa P; Buontempo F; Höcht C; Lucangioli S; Tripodi V
J Pharm Pharmacol; 2017 May; 69(5):567-573. PubMed ID: 27464712
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of two new formulations of paracetamol, compared with three marketed formulations, in healthy volunteers.
Sevilla-Tirado FJ; González-Vallejo EB; Leary AC; Breedt HJ; Hyde VJ; Fernández-Hernando N
Methods Find Exp Clin Pharmacol; 2003 Sep; 25(7):531-5. PubMed ID: 14571283
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of four oral coenzyme Q10 formulations in healthy volunteers.
Weis M; Mortensen SA; Rassing MR; Møller-Sonnergaard J; Poulsen G; Rasmussen SN
Mol Aspects Med; 1994; 15 Suppl():s273-80. PubMed ID: 7752839
[TBL] [Abstract][Full Text] [Related]
14. Comparison of bioavailability of two ubidecarenone products in healthy Korean volunteers.
Kang EY; Choi JW; Gwak HS; Chun IK
Int J Clin Pharmacol Ther; 2009 Mar; 47(3):207-14. PubMed ID: 19281730
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10).
Schulz C; Obermüller-Jevic UC; Hasselwander O; Bernhardt J; Biesalski HK
Int J Food Sci Nutr; 2006; 57(7-8):546-55. PubMed ID: 17162333
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of coenzyme Q
Ehrenhaus Masotta N; Höcht C; Contin M; Lucangioli S; Rojas AM; Tripodi VP
Int J Pharm; 2020 May; 582():119315. PubMed ID: 32283195
[TBL] [Abstract][Full Text] [Related]
17. Comparative Bioavailability of Different Coenzyme Q10 Formulations in Healthy Elderly Individuals.
Pravst I; Rodríguez Aguilera JC; Cortes Rodriguez AB; Jazbar J; Locatelli I; Hristov H; Žmitek K
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32188111
[TBL] [Abstract][Full Text] [Related]
18. A one year bioavailability study of coenzyme Q10 with 3 months withdrawal period.
Folkers K; Moesgaard S; Morita M
Mol Aspects Med; 1994; 15 Suppl():s281-5. PubMed ID: 7752840
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of two different formulations of coenzyme Q10 in healthy subjects.
Wahlqvist ML; Wattanapenpaiboon N; Savige GS; Kannar D
Asia Pac J Clin Nutr; 1998 Mar; 7(1):37-40. PubMed ID: 24394896
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone).
Constantinescu R; McDermott MP; Dicenzo R; de Blieck EA; Hyson HC; Beal MF; Bednarczyk EM; Bogdanov M; Metakis LJ; Browne SE; Lorenzo BJ; Ravina B; Kieburtz K
J Clin Pharmacol; 2007 Dec; 47(12):1580-6. PubMed ID: 17925590
[No Abstract] [Full Text] [Related]
[Next] [New Search]
